US stock · US markets · public data

ILMN

Illumina Inc · Healthcare

Reference price$269.11Updated according to the public source
P/E50.21
P/B14.32
ROE32.34%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 40.6 B
Volume (shares)1,240,696
SectorHealthcare
Overview

About ILMN

Demonstrações públicas consolidadas + SEC Company Facts

Illumina Inc (ILMN) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$4,504,000,000.00$4,372,000,000.00$4,343,000,000.00—
Gross Profit$2,744,000,000.00$2,861,000,000.00$2,870,000,000.00—
Operating Income-$1,069,000,000.00-$833,000,000.00$807,000,000.00—
Net Income-$1,161,000,000.00-$1,223,000,000.00$850,000,000.00—
EPS Diluted-$7.34 / share-$7.69 / share$5.45 / share—

Balance sheet

Account2023202420252026
Total Assets$10,111,000,000.00$6,303,000,000.00$6,644,000,000.00—
Total Equity$5,745,000,000.00$2,373,000,000.00$2,723,000,000.00—
Long-term Debt————
Current Debt————
Shares Outstanding158,000,000 shares158,900,000 shares158,400,000 shares152,900,000 shares
Cash & Investments$1,054,000,000.00$1,220,000,000.00$1,633,000,000.00—
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$478,000,000.00$837,000,000.00$1,079,000,000.00—
Capital Expenditures$195,000,000.00$128,000,000.00$148,000,000.00—
Free Cash Flow$283,000,000.00$709,000,000.00$931,000,000.00—
FAQ

Frequently asked questions

What is the price of ILMN?

The reference price available for ILMN is $269.11.

What is the P/E of ILMN?

The P/E ratio of ILMN is 50.21. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of ILMN?

The P/B of ILMN is 14.32. This compares price with reported book value per share.

What is the ROE of ILMN?

The ROE (Return on Equity) of ILMN is 32.34%. This relates the reported net result to shareholders' equity.

What is the dividend yield of ILMN?

The dividend yield of ILMN is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of ILMN?

The market capitalization of ILMN is US$ 40.6 B.

What sector is ILMN in?

ILMN operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.